PanOxyl (adapalene) NDC 0316-0284

NDC codes

FDA NDC Directory

Product NDC (as listed)0316-0284Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00316-0284Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0316-0284-15	00316028415	1 TUBE in 1 CARTON (0316-0284-15) / 15 g in 1 TUBEMarketed from Aug 8, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): PanOxyl
Generic name (nonproprietary): adapalene
Active ingredients: Adapalene — 1 mg/g
Dosage form: Gel
Route: Topical
Labeler: CROWN LABORATORIES
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215940
Marketing start: Aug 8, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 0316-0284_3bdcb3d7-164d-e678-e063-6394a90a3d6bSPL ID 3bdcb3d7-164d-e678-e063-6394a90a3d6bSPL set ID 3bdcb3d7-164e-e678-e063-6394a90a3d6bRxCUI 307731UNII 1L4806J2QFUPC 0303160284151
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400316028415 followed by a unit qualifier and the quantity

Package 00316-0284-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 8, 2025.

Indications (excerpt from the label)

Use For the treatment of acne

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215940

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215940
Product	Strength	Form · route	Labeler	Product NDC
Adapalene	Adapalene 1 mg/g	GelTopical	RITE AID	11822-0062
Adapalene	Adapalene 1 mg/g	GelTopical	RUGBY LABORATORIES, INC.	0536-1412
Adapalene	Adapalene 1 mg/g	GelTopical	AMERISOURCE BERGEN	46122-768
PanOxyladapalene	Adapalene 1 mg/g	GelTopical	CROWN LABORATORIES	0316-0143
Proactiv MD Adapalene Acne Treatmentadapalene	Adapalene .1 g/100g	GelTopical	Alchemee, LLC	11410-958
Adapalene	Adapalene 1 mg/g	GelTopical	Wal-Mart Stores Inc	79903-338
Adapalene	Adapalene 1 mg/g	GelTopical	Sun Pharmaceutical Industries, Inc.	51672-2150
Adapalene	Adapalene 1 mg/g	GelTopical	Cardinal Health	70000-0666
Adapalene	Adapalene 1 mg/g	GelTopical	YYBA Corp	73581-019
Adapalene	Adapalene 1 mg/g	GelTopical	Target Corporation	82442-105
Adapalene	Adapalene 1 mg/g	GelTopical	YYBA CORP	73581-214